Therese Mulvey, M.D.
Commonwealth Hematology-Oncology, PC

Therese M. Mulvey, President of Commonwealth Hematology-Oncology, PC, headquartered in Quincy, MA, has been with the practice since its inception in 1996. She received her MD from Tufts University School of Medicine in Boston, Massachusetts.

Board certified in Medical Oncology and Internal Medicine, Dr. Mulvey’s expertise is in breast cancer in high-risk women. She has done extensive post-graduate training in genetics, successfully completing ASCO’s curriculum as well as intensive course work in Cancer Genetic Risk Assessment at the City of Hope Cancer Center in Duarte, California. Dr. Mulvey is a member of the National Society of Genetic Counselors, she is recognized on the National Cancer Institute web site as a genetic risk assessment counselor, and heads up the genetics program at Commonwealth Hematology-Oncology.

Associate Editor of the Journal of Oncology Practice (JOP), Dr. Mulvey currently chairs ASCO’s Clinical Practice Committee and Annual Meeting Tract Chair, Practice Management. She is also a past President, Vice President and Board Member of Massachusetts Society of Clinical Oncology.

Commonwealth Hematology-Oncology (CHO), with offices and clinical sites throughout Massachusetts, is the largest private practice cancer care network in New England. Known for its leadership in community-based cancer care, CHO physicians have been caring for patients for over three decades. CHO was the first group practice in the state to develop treatment guidelines for specific cancers, the first to develop a computerized software program for chemotherapy ordering, the first to create a free patient advocacy program, and the only area practice to be selected by the National Cancer Institute to offer community-based clinical trials. CHO also provides genetic testing to community residents at high risk for cancer.

.